A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9).
Wendy S LaneElena FavaroNaveen RathorHak Chul JangMaiken I S KjærsgaardAlejandra OviedoLudger RosePeter SeniorGiorgio SestiAlfonso Soto GonzalezEdward FranekPublished in: Diabetes care (2020)
In combination with insulin degludec, faster aspart provided effective overall glycemic control, superior PPG control, and a lower rate of severe or BG-confirmed hypoglycemia versus IAsp in adults with type 2 diabetes not optimally controlled with a basal-bolus regimen.